A5045686648- Global Maternal and Child Health
- Healthcare Systems and Reforms
- HIV/AIDS Impact and Responses
- International Development and Aid
- Global Health Care Issues
- Vaccine Coverage and Hesitancy
- COVID-19 epidemiological studies
- Global Public Health Policies and Epidemiology
- SARS-CoV-2 and COVID-19 Research
- Global Health and Surgery
- Religion, Society, and Development
- Health Systems, Economic Evaluations, Quality of Life
- COVID-19 and healthcare impacts
- COVID-19 Clinical Research Studies
- Parasites and Host Interactions
- Public Procurement and Policy
- Human Rights and Development
- COVID-19 Pandemic Impacts
- Islamic Studies and History
- Parasite Biology and Host Interactions
- Health Services Management and Policy
- Viral Infections and Outbreaks Research
- Global Health Workforce Issues
- Primary Care and Health Outcomes
- HIV/AIDS Research and Interventions
Duke University
2019-2024
Duke Institute for Health Innovation
2019-2024
Impact
2019-2023
Northeastern University
2023
Monash University
2023
World Health Organization
2023
Mahidol University
2023
International Management Institute
2023
United Nations Economic and Social Commission for Asia and the Pacific
2023
The University of Adelaide
2023
During the covid-19 pandemic, we have seen best of international collective action and its limits.Global scientific cooperation drove development safe, highly effective vaccines in under one year. 1Yet also witnessed global vaccine inequity, 2 which low middle income countries "limited supply limited brand options." 3 With omicron wave dissipating, several well vaccinated high nations with stockpiles are rushing to declare pandemic over, reminding us how things unfolded tuberculosis,...
### Summary box Progress in developing COVID-19 vaccines has been rapid: the first clinical trial of a vaccine candidate began Seattle, USA on 16 March 2020—just 63 days after China shared genetic sequence SARS-CoV-2, virus that causes COVID-19. As 12 November 2020, there were 48 trials.1 Given standard attrition rates, we can expect at least handful to eventually be launched. However, safe, effective alone will not enough end pandemic. The must also delivered globally price affordable all...
Twelve multilateral health and development organizations have signed on to a joint Global Action Plan for Healthy Lives Well-being All (the Plan). The includes call signatory align efforts strengthen the provision of global public goods (GPGs) health. In this paper, we examined support GPGs health, focusing four largest — Gavi, Vaccine Alliance; Fund Fight AIDS, Tuberculosis Malaria; World Bank; Health Organization. Our analysis aimed understand how these define such goods. Taking...
West Africa's Ebola epidemic of 2014-2016 exposed, among other problems, the under-funding transnational global health activities known as common goods for (CGH), functions such pandemic preparedness and research development (R&D) neglected diseases. To mobilize sustainable funding CGH, it is critical first to understand existing financing flowing different types CGH. In this study, we estimate trends in international spending CGH 2013, 2015, 2017, encompassing era before after epidemic. We...
Ghana's shift from low-income to middle-income status will make it ineligible receive concessional aid in the future. While transition may be a reflection of positive changes country, such as economic development or health progress, loss support donor agencies could have negative impacts on system performance and population health. We aimed identify key challenges opportunities that Ghana face dealing with transition, specifically point view country-level stakeholders.
Schistosomiasis is caused by parasitic flatworms (Schistosoma). The disease in humans can be seven different species of Schistosoma: S. mansoni, japonicum, haematobium, malayensis, mekongi, guineensis and intercalatum, as well hybrids between species, including livestock schistosome species. People are infected when exposed to infested water the parasite larvae penetrate skin. Poor rural communities typically most affected, general population who lives affected areas contaminated at risk....
The coronavirus pandemic (COVID-19) has triggered a public health and economic crisis in high low resource settings since the beginning of 2020. With first case being discovered on 12th March 2020, Kenya responded by using non-health strategies to mitigate direct indirect impact disease its population. However, this had positive negative implications for country's overall system. This paper aimed understand pandemic's develop lessons future response identifying key challenges opportunities...
The motivations behind China’s allocation of health aid to Africa remain complex due limited information on the details project activities. Insufficient knowledge about purpose hinders our understanding comprehensive role in supporting Africa’s healthcare system. To address this gap, study aimed gain better insights into priorities and factors driving these across Africa. achieve this, we utilized AidData’s Chinese Official Finance Dataset adhered Organisation for Economic Co-operation...
Although it is difficult to quantify, previous estimates suggested that China's global health aid has increased sharply since the early 2000s. Unlike many donors, China no official reporting obligations, nor does voluntarily disclose detailed information. Our study aimed create a standardised estimate using commonly accepted definitions of and frameworks for categorising projects.We categorised AidData's Chinese Official Finance Dataset health-related projects according from Organisation...
China is emerging as an increasingly important player in the global development space, but may be less bound to compacts that aim curb political preferencing and therefore produce yield terms of impact toward Sustainable Development Goals. This research tests hypothesis disproportionate aid allocation birth regions current African leaders applies some sectors more than others.We applied a two-part model first estimate probability region receives project. Then when at least one project...
The global aid landscape is rapidly changing. So-called ‘emerging’ or ‘non-traditional’ donors (ie, those that have only recently substantially stepped up their development finance support) are pushing the boundaries of existing practices. Among such non-traditional donors, China stands out as a major player because its recent high-profile commitments, like Belt and Road Initiative, role in establishing new institutions, Asian Infrastructure Investment Bank. Although often thought donor,...
Many donors are reconsidering their approach to providing health aid countries that viewed as becoming increasingly capable of self-financing own development. To better understand this phenomenon, we analyzed the transition approaches adopted by six key global donors, three multilateral and bilateral, who provided nearly 75% all disbursed official development assistance for in 2016. We conducted a desk-based review triangulated our findings with semi-structured informant interviews.We found:...
There have been significant improvements in recent years the early stage development of products for poverty-related and neglected diseases (PRNDs). However, there are still major challenges funding late-stage clinical trials candidate these diseases. For vaccine specifically, Rappuoli colleagues recently concluded that "these process revealed a new, possibly more perilous, Valley Death late phase." three conducting phase III PRND product development. First, such expensive companies often...
Background The United Kingdom (UK) used to be the second largest bilateral provider of official development assistance (ODA) for health. However, in 2021 UK government cut its annual aid budget by 30%. We aim understand how these cuts might affect financing health systems recipient countries. Methods conducted a retrospective analysis domestic and external funding 134 countries that received 2019–2020 year. grouped into two cohorts: those continued receive 2020–2021 (“budget”) did not (“no...
Poverty-related and neglected diseases (PRNDs) cause over three million deaths annually. Despite this burden, there is a large gap between actual funding for PRND research development (R&D) the needed to launch products from R&D pipeline. This study provides an economic evaluation of theoretical global pooled-funding mechanism finance late-stage clinical trials products.We modelled design options, each based on different level coverage candidate WHO's list PRNDs: (1) vaccines covering 4...
As more countries move from low- to middle-income status, they are perceived as increasingly capable of financing their own health systems. Some donors have begun transition support out such (MICs) redirect funds with greater needs. However, this may leave a funding gap for MICs that could be difficult fill when external resources decline. If not carefully managed, financial shifts lead the loss gains occurred while receiving substantial support. Understanding levels donor dependency (i.e.,...
Kenya has progressed towards implementing and institutionalizing strategic health purchasing (SHP) practices as a key strategy to achieving universal coverage (UHC). However, multiple challenges are faced such fragmentation of pooling arrangements, inadequate funding, rigid public financial management requirements, lack purchaser-provider split formal policies laws support SHP. Given these challenges, we conducted mixed methods study understand lessons on the reforms in Kenya. We...
BackgroundChinese global health aid has expanded tremendously since the 2000s. Unlike many donors, China no official reporting obligations, nor does it voluntarily disclose detailed information. Therefore, several third parties have attempted to estimate China's footprint. However, current estimates use varied definitions of aid, geographic regions, and time spans. These distinct methodological approaches make comparisons Chinese other donors difficult. Our study builds on previous tracking...
The coronavirus pandemic (COVID-19) has triggered a public health and economic crisis in both high low resource settings since the beginning of 2020. With first case being discovered on 12th March 2020, Kenya responded using non-health strategies to mitigate direct indirect impact disease its population. However, this had positive negative implications for country's overall system. This paper aimed understand pandemic's develop lessons future response by identifying key challenges...